Responses
Section 5: Patient safety and quality assurance
5PSQ-014 Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel – towards crisis management and a premedication reconsideration in France (PACLIREACT Study)
Compose a Response to This Article
Other responses
No responses have been published for this article.